Xgenera
Dr. Andy Shapanis currently serves as the Chief Executive Officer of Xgenera since January 2023 and holds the position of Senior Research Fellow at the University of Southampton, a role undertaken since March 2019. Dr. Shapanis earned a Doctor of Philosophy in Oncology and Cancer Biology from the University of Southampton from September 2015 to March 2019, and previously completed a Master of Research in Biomedical Sciences with a focus on General and Translational Medicine at the University of Liverpool from 2014 to 2015. The academic journey began with a Bachelor of Science in Microbiology from Aberystwyth University, completed between 2011 and 2014.
This person is not in the org chart
This person is not in any teams
Xgenera
Xgenera is dedicated to transforming cancer diagnosis through their groundbreaking multi-cancer early detection (MCED) test. With a mission to save lives by identifying cancer at its earliest stages, Xgenera leverages cutting-edge technology and advanced algorithms to detect a wide range of cancers with exceptional accuracy. By detecting cancer earlier, when treatment options are most effective, Xgenera aims to improve patient outcomes and ultimately reduce the global burden of cancer. Backed by data from large patient cohorts and ongoing research, Xgenera's MCED test holds the potential to revolutionise cancer diagnosis around the world. With a commitment to empowering individuals and healthcare providers with timely, actionable information, Xgenera is at the forefront of the fight against cancer, paving the way for a future where early detection saves lives.